Chadox1 Ncov-19 Vaccination: A Clinico-Pathological Review of Coagulation Derangement in Four Cases
DOI:
https://doi.org/10.14738/jbemi.95.12912Keywords:
ChAdOx1 nCoV-19, Covid 19, Covid Vaccination, Astrazeneca, Johnson and JohnsonAbstract
BACKGROUND: Mass vaccination of the populace was one of the responses to mitigate the Severe Acute Respiratory Syndrome Coronavirus 2 (SARs CoV-2) pandemic. Some minor and major adverse effects have been reported. METHODS: This study reviewed the clinico-pathologic parameters of 4 patients with clinical and biochemical coagulation abnormalities following the administration of the Oxford AstraZeneca COVID-19 (ChAdOx1 nCoV-19) vaccination. Their clinical, laboratory and radiological parameters were retrieved and documented. RESULTS: All the patients had abnormality of coagulation with thrombus formation. Two of the reported patients had several risk factors for thrombosis and thus their diseases may not have causal relationship with the vaccination while the other 2 patients had no plausible clinical explanation for their coagulation abnormality. Mortality was recorded in two of the patients. CONCLUSION: Severe adverse effect of ChAdOx1 nCoV-19 Vaccination may not be rare. Physicians should have a high index of suspicion and there is also a need to upscale adverse events monitoring.
References
Dadax. Wordometer-Real time world statistics. https://wwwworldometersinfo/coronavirus/. 2021.
https://www.who.int/vaccine_safety/initiative/detection/AEFI/en/. Adverse Events Following Immunization (AEFI). 2021.
Tobaiqy M, Elkout H, MacLure K. Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database. Vaccines. 2021;9(4).
Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. The New England journal of medicine. 2021.
Maas D, Kramers C, Smit H, Middeldorp S, Helsloot I. [Temporary suspension of AstraZeneca's vaccine; a reconstruction]. Nederlands tijdschrift voor geneeskunde. 2021;165.
Allen A SL, Kaiser Health News. NIH “Very Concerned” about Serious Side Effect in Coronavirus Vaccine Tria. Health News. 2020.
Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet (London, England). 2021;397(10269):99-111.
Ledford H. US authorization of first COVID vaccine marks new phase in safety monitoring. Nature. 2020;588(7838):377-8.
Goss AL, Samudralwar RD, Das RR, Nath A. ANA Investigates: Neurological Complications of COVID-19 Vaccines. Annals of neurology. 2021;89(5):856-7.
Wolf ME, Luz B, Niehaus L, Bhogal P, Bäzner H, Henkes H. Thrombocytopenia and Intracranial Venous Sinus Thrombosis after “COVID-19 Vaccine AstraZeneca” Exposure. Journal of Clinical Medicine. 2021;10(8):1599. 19
Schultz NH, Sørvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. New England Journal of Medicine. 2021.
Muir K-L, Kallam A, Koepsell SA, Gundabolu K. Thrombotic Thrombocytopenia after Ad26. COV2. S Vaccination. New England Journal of Medicine. 2021.
Oldenburg J, Klamroth R, Langer F, Albisetti M, von Auer C, Ay C, et al. Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH. Hamostaseologie. 2021.
Hematology ASo. Thrombosis with Thrombocytopenia Syndrome. https://wwwhematologyorg/covid-19/vaccine-induced-immune-thrombotic-thrombocytopenia. 2021.
Schultz NH, Sørvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. The New England journal of medicine. 2021.
Wise J. Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots. BMJ (Clinical research ed). 2021;372:n699.
Helms JM, Ansteatt KT, Roberts JC, Kamatam S, Foong KS, Labayog JS, et al. Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine. Journal of blood medicine. 2021;12:221-4.
Lee EJ, Cines DB, Gernsheimer T, Kessler C, Michel M, Tarantino MD, et al. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. American journal of hematology. 2021;96(5):534-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 A. O. Adekoya, F. Adelekan-Popoola, A. O. Fabamwo, E. A. Abayomi, A. O. Ajibare, B. Odugbemi, S. S. Soyemi
This work is licensed under a Creative Commons Attribution 4.0 International License.
